Personalized medicine: An overview

Vijay Mishra, Puja Chanda, Murtaza M. Tambuwala, Ashish Suttee

Research output: Contribution to journalReview article

Abstract

Personalized medicine is a model for health care which is a combination of preventive, personalized, participatory and predictive measures. It is an approach for better treatment by identifying the disease causing genomic makeup of an individual. Personalized medicine is a broad field and it can be used for the diagnosis of various diseases like cancers, Alzheimer, Hepatitis, Cardiac diseases etc. It is an emerging field with lots of hope in the future. This review is basically based on characteristics of personalized medicine and its implementation in various diseases like lung cancer, renal cancer and rheumatoid arthritis. Further, the initiation taken by the European Union towards the development of personalized medicine and the challenges faced during the data collection, development of medicine and clinical trials were also discussed. The personalized medicine coalitions (PMC) have approved various novel medicines as personalized medicine under US FDA.

LanguageEnglish
Pages290-294
Number of pages5
JournalInternational Journal of Pharmaceutical Quality Assurance
Volume10
Issue number2
Early online date25 Jun 2019
DOIs
Publication statusE-pub ahead of print - 25 Jun 2019

Fingerprint

Precision Medicine
Kidney Neoplasms
European Union
Hepatitis
Heart Diseases
Lung Neoplasms
Rheumatoid Arthritis
Medicine
Clinical Trials
Delivery of Health Care
Neoplasms

Keywords

  • Genome
  • Lung cancer
  • Personalized medicine
  • Renal cancer
  • Rheumatoid arthritis

Cite this

Mishra, Vijay ; Chanda, Puja ; Tambuwala, Murtaza M. ; Suttee, Ashish. / Personalized medicine: An overview. In: International Journal of Pharmaceutical Quality Assurance. 2019 ; Vol. 10, No. 2. pp. 290-294.
@article{ecb22df579e44a9a80fcdc7673699d40,
title = "Personalized medicine: An overview",
abstract = "Personalized medicine is a model for health care which is a combination of preventive, personalized, participatory and predictive measures. It is an approach for better treatment by identifying the disease causing genomic makeup of an individual. Personalized medicine is a broad field and it can be used for the diagnosis of various diseases like cancers, Alzheimer, Hepatitis, Cardiac diseases etc. It is an emerging field with lots of hope in the future. This review is basically based on characteristics of personalized medicine and its implementation in various diseases like lung cancer, renal cancer and rheumatoid arthritis. Further, the initiation taken by the European Union towards the development of personalized medicine and the challenges faced during the data collection, development of medicine and clinical trials were also discussed. The personalized medicine coalitions (PMC) have approved various novel medicines as personalized medicine under US FDA.",
keywords = "Genome, Lung cancer, Personalized medicine, Renal cancer, Rheumatoid arthritis",
author = "Vijay Mishra and Puja Chanda and Tambuwala, {Murtaza M.} and Ashish Suttee",
year = "2019",
month = "6",
day = "25",
doi = "10.25258/ijpqa.10.2.13",
language = "English",
volume = "10",
pages = "290--294",
journal = "International Journal of Pharmaceutical Quality Assurance",
issn = "0975-9506",
number = "2",

}

Personalized medicine: An overview. / Mishra, Vijay; Chanda, Puja; Tambuwala, Murtaza M.; Suttee, Ashish.

In: International Journal of Pharmaceutical Quality Assurance, Vol. 10, No. 2, 25.06.2019, p. 290-294.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Personalized medicine: An overview

AU - Mishra, Vijay

AU - Chanda, Puja

AU - Tambuwala, Murtaza M.

AU - Suttee, Ashish

PY - 2019/6/25

Y1 - 2019/6/25

N2 - Personalized medicine is a model for health care which is a combination of preventive, personalized, participatory and predictive measures. It is an approach for better treatment by identifying the disease causing genomic makeup of an individual. Personalized medicine is a broad field and it can be used for the diagnosis of various diseases like cancers, Alzheimer, Hepatitis, Cardiac diseases etc. It is an emerging field with lots of hope in the future. This review is basically based on characteristics of personalized medicine and its implementation in various diseases like lung cancer, renal cancer and rheumatoid arthritis. Further, the initiation taken by the European Union towards the development of personalized medicine and the challenges faced during the data collection, development of medicine and clinical trials were also discussed. The personalized medicine coalitions (PMC) have approved various novel medicines as personalized medicine under US FDA.

AB - Personalized medicine is a model for health care which is a combination of preventive, personalized, participatory and predictive measures. It is an approach for better treatment by identifying the disease causing genomic makeup of an individual. Personalized medicine is a broad field and it can be used for the diagnosis of various diseases like cancers, Alzheimer, Hepatitis, Cardiac diseases etc. It is an emerging field with lots of hope in the future. This review is basically based on characteristics of personalized medicine and its implementation in various diseases like lung cancer, renal cancer and rheumatoid arthritis. Further, the initiation taken by the European Union towards the development of personalized medicine and the challenges faced during the data collection, development of medicine and clinical trials were also discussed. The personalized medicine coalitions (PMC) have approved various novel medicines as personalized medicine under US FDA.

KW - Genome

KW - Lung cancer

KW - Personalized medicine

KW - Renal cancer

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=85071365696&partnerID=8YFLogxK

U2 - 10.25258/ijpqa.10.2.13

DO - 10.25258/ijpqa.10.2.13

M3 - Review article

VL - 10

SP - 290

EP - 294

JO - International Journal of Pharmaceutical Quality Assurance

T2 - International Journal of Pharmaceutical Quality Assurance

JF - International Journal of Pharmaceutical Quality Assurance

SN - 0975-9506

IS - 2

ER -